0 comments
The safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date versions. Therefore, we wish to inform you of the following changes to the lists on the website: Fluvoxamine (brand names Faverin®, Fevarin®, Floxyfral®, Dumyrox® and Luvox®), a drug used to treat obsessive-compulsive disorder and other psychiatric illnesses, has been added to the list of drugs with Conditional Risk of torsades de pointes (TdP). Its use has been associated with TdP under certain conditions, especially when used in excessive doses or with drugs that prolong the QT interval. Amphotericin B (brand names Fungilin®, Fungizone®, Abelcet®, AmBisome®, Fungisome®, Amphocil®, Amphotec®) is an antifungal drug found to be associated with TdP under certain conditions, especially when used with drugs that prolong the QT interval, when it has induced hypokalemia or when given by rapid infusion. Therefore, it has also been added to the Conditional Risk list. The antipsychotic zotepine (brand names Losizopilon®, Lodopin®, Setous® and Zoleptil®) has been added to the list of drugs with Possible Risk of TdP. Another antipsychotic, sultopride (brand names Barnotil®, Topral®, Barnetil®), a drug marketed in Asia and some European countries, has been added to the list of drugs with Known Risk of TdP.
View Post
1 comment
SADS 9th Annual International Conference: Putting it Together: From the Genome to the Phenotype
Jul
08
The Sudden Arrhythmic Death Syndromes (SADS) Foundation is hosting its annual conference in San Diego from September 30 through October 2nd.
View Post
0 comments
Drs. Peter Schwartz and Ray Woosley publish review: Predicting the Unpredictable - Drug-induced QT Prolongation and TdP
View Post
520-989-0900 
1822 E. Innovation Park Dr. Oro Valley, Arizona 85755